Search
Now showing items 1-3 of 3
Economic evaluation of supplementing the diet with 1 Souvenaid in patients with prodromal Alzheimer's disease
(BioMed Central Ltd. Part of Springer Nature, 2020)
Background: The LipiDiDiet trial showed that Souvenaid, a medical food, might delay progression to dementia in prodromal Alzheimer’s disease (AD). The objective of this study was to assess the cost-utility of Souvenaid ...
Dementia related neuropsychiatric symptoms: inequalities in pharmacological treatment and institutionalization
(Dove Medical Press Limitedprevalence, 2019)
Background: Dementia-related neuropsychiatric symptoms (NPS) are the main determinant
of family stress and institutionalization of patients. This study aimed to identify inequalities
by gender and socioeconomic status ...
Budget impact analysis of the use of Souvenaid in patients with prodromal Alzheimer’s Disease in Spain
(Springer Nature, 2022)
Introduction
The effectiveness, safety, and cost-effectiveness of the use of Souvenaid for Alzheimer’s disease (AD) have been previously evidenced. To complete the economic analysis, there is a need to assess whether ...
